A Agência Nacional de Vigilância Sanitária (Anvisa) aprovou no dia 20 de outubro de 2025 o uso do Mounjaro, cujo princípio ativo é a (…)
Advancements in medicine have increased life expectancy. Nevertheless, several new challenges remain in improving quality of life. With aging (...)
Due to the high prevalence of obstructive sleep apnea , numerous studies are being conducted to expand diagnostic methods. Research groups worldwide, composed of highly competent (...)
According to the Brazilian National Cancer Institute (INCA, for its Portuguese acronym), an estimated 704,000 new cancer cases are expected annually in Brazil between 2023 and 2025. Given (...)
If you want to improve the materials used and the effectiveness of oral appliances for treating obstructive sleep apnea (OSA), remember that their (...)
The primary OSA therapies—CPAP and oral appliances—require continuous use during sleep. Studies highlight that (...)
Did you know that untreated sleep apnea can accelerate the progression of insulin resistance in postmenopausal women? This issue (...)
Sleep apnea is a condition which affects millions of people worldwide and, when left untreated, can lead to severe cardiovascular health consequences (...)
A solução Biologix representa um avanço significativo na detecção de intensidade do ronco. Com o auxílio da inteligência artificial, o Teste do Ronco Biologix® (…)
Atrial fibrillation (AFib) is one of the most common examples of cardiac arrhythmia with significant clinical importance. This supraventricular arrhythmia is characterized by a complete disorganization of atrial electric activity (...)